Skip to main content
  • Home

Recent Posts by our contributor, joseph mansour

FDA approves breakthrough breast cancer drug
Mon, 06/11/2012 - 2:57pm

In an unprecedented breakthrough in breast cancer research, the FDA approved a new drug that should improve on the treatment of one of the most deadly forms of breast cancer to date, HER2-positive.

Alzheimer's drug disappoints
Wed, 08/08/2012 - 3:00pm

Pfizer and Johnson & Johnson stated on Monday that they have ended the development of an intravenous drug that was supposed to aid patients with Alzheimer’s disease, according to Bloomberg.com.

Follow us:
  • facebook
  • twitter
  • YouTube

 

  • Popular
  • Recent
  • Tags
  • Woman files spina bifida lawsuit against Abbott Laboratories

    • Dec 22, 2011
  • Victims continue to file Actos lawsuits against Takeda Pharmaceuticals

    • Jan 26, 2012
  • Wave of lawsuits continue against Takeda Pharmaceuticals

    • Dec 22, 2011
  • Canadian study shows Actos doubles bladder cancer risk

    • Jun 8, 2012
  • FDA approves prescription fish oil

    • Jul 30, 2012
  • FDA Reports Metal-on-Metal Hip Implant Statistics

    • Jun 22, 2012
  • FDA issues warning after codeine kills children post-surgery

    • Aug 16, 2012
  • Artificial retina gives sight to blind mice

    • Aug 16, 2012
  • Lucentis approved for diabetic macular edema

    • Aug 14, 2012
  • Mayo Clinic: Patients in the dark about prescriptions

    • Aug 9, 2012
  • Hospital's plan to prevent painkiller abuse

    • Aug 8, 2012
  • Alzheimer's drug disappoints

    • Aug 8, 2012
Bayer pulmonary embolism stroke Johnson & Johnson type 2 diabetes breast cancer Urban HIV test lorcaserin Gynecare Prolift pulomonary embolism Tempah Yaz Zocor dabigatran venous thromboembolism colon cancer EMA acetaminophen blood clots Zimmer pulmonary embolism MenHibrix statin chemotherapy Photography Nature yo Products blood thinner

More Dangerous Drug News

Lipitor Type 2 Diabetes Lawsuit

Get News Updates By Email

@ConsumerDrugRep Tweets

Archives

  • June 2012 (32)
  • July 2012 (31)
  • August 2012 (10)

Pages

  • « first
  • ‹ previous
  • 1
  • 2
Saturday, 2 July 2022
  • Subscribe by RSS
Consumer Drug Report
  • Tylenol
  • Miscellaneous
    • Avaira
  • Antidepressants
  • Fosamax
  • Pradaxa
  • Actos
  • Yaz
About Us

From side effects to recalls to pending lawsuits, Consumer Drug Report keeps you up to date with the latest information on pharmaceutical safety.

To submit questions or story ideas, please post on our Consumer Drug Report Facebook page,

tweet at us @ConsumerDrugRep, or

email us at news@consumer-drug-report.com.

Details

Home

About

Contact

Privacy

Sitemap 

Disclaimer

Categories
  • Actos
  • Antidepressants
  • Avaira
  • Fosamax
  • Miscellaneous
  • Pradaxa
  • Tylenol
  • Yaz

Brought to you by Spangenberg Shibley & Liber, LLP © 2012